Steward Partners Investment Advisory, LLC Astrazeneca PLC Transaction History

Steward Partners Investment Advisory, LLC

$10.6 Billion
Q3 2024

A detailed history of Steward Partners Investment Advisory, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Steward Partners Investment Advisory, LLC holds 94,242 shares of AZN stock, worth $6.16 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

94,242

Previous 94,012 0.24%

Holding current value

$6.16 Million

Previous $7.33 Million 0.16%

% of portfolio

0.07%

Previous 0.08%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$76.67 - $87.62 $17,634 - $20,152	230 Added 0.24%	94,242 $7.34 Million
Q2 2024 Aug 08, 2024	BUY	$66.81 - $80.83 $62,333 - $75,414	933 Added 1.0%	94,012 $7.33 Million
Q1 2024 May 15, 2024	BUY	$61.03 - $69.57 $264,259 - $301,238	4,330 Added 4.88%	93,079 $6.31 Million
Q4 2023 Feb 12, 2024	SELL	$61.89 - $69.28 $43,075 - $48,218	-696 Reduced 0.78%	88,749 $5.98 Million
Q3 2023 Nov 13, 2023	BUY	$64.85 - $71.7 $30,933 - $34,200	477 Added 0.54%	89,445 $6.06 Million
Q2 2023 Aug 14, 2023	BUY	$69.91 - $75.81 $98,013 - $106,285	1,402 Added 1.6%	88,968 $6.37 Million
Q1 2023 May 15, 2023	SELL	$63.15 - $71.6 $905,318 - $1.03 Million	-14,336 Reduced 14.07%	87,566 $6.08 Million
Q4 2022 Feb 15, 2023	SELL	$54.21 - $70.44 $108,420 - $140,880	-2,000 Reduced 1.92%	101,902 $6.91 Million
Q3 2022 Nov 10, 2022	BUY	$53.02 - $135.75 $58,322 - $149,325	1,100 Added 1.07%	103,902 $5.7 Million
Q2 2022 Aug 04, 2022	BUY	$59.26 - $71.14 $2,370 - $2,845	40 Added 0.04%	102,802 $6.79 Million
Q1 2022 May 02, 2022	BUY	$55.72 - $67.12 $157,854 - $190,150	2,833 Added 2.84%	102,762 $6.82 Million
Q4 2021 Feb 08, 2022	BUY	$54.02 - $63.83 $91,888 - $108,574	1,701 Added 1.73%	99,929 $5.82 Million
Q3 2021 Nov 12, 2021	BUY	$55.56 - $60.79 $337,915 - $369,724	6,082 Added 6.6%	98,228 $5.9 Million
Q2 2021 Aug 13, 2021	BUY	$48.42 - $60.18 $151,215 - $187,942	3,123 Added 3.51%	92,146 $5.52 Million
Q1 2021 May 14, 2021	BUY	$47.16 - $54.44 $571,815 - $660,085	12,125 Added 15.77%	89,023 $4.43 Million
Q4 2020 Feb 11, 2021	BUY	$48.52 - $58.02 $2.45 Million - $2.93 Million	50,583 Added 192.22%	76,898 $3.84 Million
Q3 2020 Oct 30, 2020	BUY	$53.07 - $61.1 $111,287 - $128,126	2,097 Added 8.66%	26,315 $1.44 Million
Q2 2020 Aug 06, 2020	BUY	$43.1 - $55.31 $44,824 - $57,522	1,040 Added 4.49%	24,218 $1.28 Million
Q1 2020 Apr 29, 2020	SELL	$37.79 - $51.33 $3,741 - $5,081	-99 Reduced 0.43%	23,178 $1.04 Million
Q4 2019 Jan 17, 2020	BUY	$42.46 - $50.46 $111,499 - $132,507	2,626 Added 12.72%	23,277 $1.16 Million
Q3 2019 Oct 30, 2019	BUY	$40.12 - $45.47 $11,033 - $12,504	275 Added 1.35%	20,651 $920,000
Q2 2019 Jul 25, 2019	BUY	$37.28 - $41.68 $38,994 - $43,597	1,046 Added 5.41%	20,376 $841,000
Q1 2019 Apr 30, 2019	SELL	$35.49 - $43.02 $54,832 - $66,465	-1,545 Reduced 7.4%	19,330 $781,000
Q4 2018 Jan 15, 2019	BUY	$36.86 - $41.49 $48,102 - $54,144	1,305 Added 6.67%	20,875 $792,000
Q3 2018 Oct 23, 2018	BUY	$34.76 - $39.72 $68,094 - $77,811	1,959 Added 11.12%	19,570 $774,000
Q2 2018 Jul 20, 2018	BUY	$34.55 - $37.05 $48,231 - $51,721	1,396 Added 8.61%	17,611 $618,000
Q1 2018 Apr 20, 2018	BUY	$32.97 - $36.63 $45,663 - $50,732	1,385 Added 9.34%	16,215 $567,000
Q4 2017 Jan 19, 2018	BUY	$32.09 - $34.78 $22,238 - $24,102	693 Added 4.9%	14,830 $514,000
Q3 2017 Nov 22, 2017	SELL	$28.96 - $34.0 $15,088 - $17,714	-521 Reduced 3.55%	14,137 $478,000
Q2 2017 Nov 22, 2017	BUY	N/A	4,281 Added 41.25%	14,658 $499,000
Q1 2017 Nov 22, 2017	BUY	N/A	2,379 Added 29.74%	10,377 $323,000
Q4 2016 Nov 22, 2017	BUY	N/A	7,998	7,998 $218,000

Others Institutions Holding AZN

# of Institutions

1,361

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $203B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Steward Partners Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Steward Partners Investment Advisory, LLC with notifications on news.

Account

Steward Partners Investment Advisory, LLC Astrazeneca PLC Transaction History